I’m currently a fourth-year student in the Graduate School of Biomedical Sciences-Cancer Biology Program at UT Health San Antonio and Affiliate Member of the UT MD Anderson/Mays Cancer Center, San Antonio, Texas. I am committed to improving our understanding of breast and gynecologic cancers with a goal of developing next-generation translational cancer therapeutics and prevention interventions to positively enhance disease-free interval and survival outcomes. My research is dedicated to uncovering the mechanistic contributions of oncogenes, epigenetics, and hormonal signaling spearheaded toward the development of novel translational advances in women’s cancer therapeutics. My dissertation research focuses on the development and characterization of a first-in-class small-molecule inhibitor of the proto-oncogenic PELP1 protein for the treatment of advanced breast cancers.
I attended my first AACR conference in 2019, and since then I have attended many of the Associate Member Council (AMC) career development events. In 2021, I had the privilege of participating in the 2021 Virtual AACR-Early Career Hill Day. I am honored and excited to be joining the AMC, and I hope to utilize my skills and experiences to further develop programs and resources that will benefit my fellow early-career researchers and serve the AACR Associate member community.